Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders??? Equity

v3.22.2
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Common stock, beginning balance (in shares) at Dec. 31, 2020   121,922,532      
Beginning balance at Dec. 31, 2020 $ 395,204,334 $ 121,923 $ 504,112,442 $ (109,030,031) $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock options and warrants exercised, and vesting of restricted shares (in shares)   1,491,513      
Stock options and warrants exercised, and vesting of restricted shares (69,416) $ 1,491 (70,907)    
Stock-based compensation 2,032,341   2,032,341    
Net loss (164,125,858)     (164,125,858)  
Other comprehensive loss (10,200,000)       (10,200,000)
Common stock, ending balance (in shares) at Jun. 30, 2021   123,414,045      
Ending balance at Jun. 30, 2021 222,841,401 $ 123,414 506,073,876 (273,155,889) (10,200,000)
Common stock, beginning balance (in shares) at Mar. 31, 2021   123,254,853      
Beginning balance at Mar. 31, 2021 275,604,211 $ 123,255 505,017,758 (229,536,802) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock options and warrants exercised, and vesting of restricted shares (in shares)   159,192      
Stock options and warrants exercised, and vesting of restricted shares (83,636) $ 159 (83,795)    
Stock-based compensation 1,139,913   1,139,913    
Net loss (43,619,087)     (43,619,087)  
Other comprehensive loss (10,200,000)       (10,200,000)
Common stock, ending balance (in shares) at Jun. 30, 2021   123,414,045      
Ending balance at Jun. 30, 2021 $ 222,841,401 $ 123,414 506,073,876 (273,155,889) (10,200,000)
Common stock, beginning balance (in shares) at Dec. 31, 2021 151,915,455 151,915,455      
Beginning balance at Dec. 31, 2021 $ 174,692,773 $ 151,916 686,318,201 (510,374,844) (1,402,500)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issued in exchange of convertible notes (in shares)   7,833,666      
Common stock issued in exchange of convertible notes 25,381,078 $ 7,834 25,373,244    
Common stock issued through At-The-Market offering (in shares)   98,986      
Common stock issued through At-The-Market offering 248,695 $ 99 248,596    
Stock options and warrants exercised, and vesting of restricted shares (in shares) [1]   210,405      
Stock options and warrants exercised, and vesting of restricted shares [1] (324,488) $ 210 (324,698)    
Stock-based compensation 5,642,702   5,642,702    
Net loss (43,214,807)     (43,214,807)  
Other comprehensive loss $ 1,402,500       1,402,500
Common stock, ending balance (in shares) at Jun. 30, 2022 160,058,512 160,058,512      
Ending balance at Jun. 30, 2022 $ 163,828,453 $ 160,059 717,258,045 (553,589,651) 0
Common stock, beginning balance (in shares) at Mar. 31, 2022   151,993,870      
Beginning balance at Mar. 31, 2022 156,194,769 $ 151,994 688,472,154 (532,429,379) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issued in exchange of convertible notes (in shares)   7,833,666      
Common stock issued in exchange of convertible notes 25,381,078 $ 7,834 25,373,244    
Common stock issued through At-The-Market offering (in shares)   98,986      
Common stock issued through At-The-Market offering 248,695 $ 99 248,596    
Stock options and warrants exercised, and vesting of restricted shares (in shares) [1]   131,990      
Stock options and warrants exercised, and vesting of restricted shares [1] (128,226) $ 132 (128,358)    
Stock-based compensation 3,292,409   3,292,409    
Net loss $ (21,160,272)     (21,160,272)  
Common stock, ending balance (in shares) at Jun. 30, 2022 160,058,512 160,058,512      
Ending balance at Jun. 30, 2022 $ 163,828,453 $ 160,059 $ 717,258,045 $ (553,589,651) $ 0
[1] Net of tax payments related to shares withheld for option exercises and vested stock.